Targeting the ADA/ADO Axis Rescues β-Cell Failure in Type 2 Diabetes
Yingxin Zhang(Yangtze University), Jianfa Zhang(Nanjing University of Science and Technology), Ning Yu(Nanjing University of Science and Technology), Rui Fang(German Cancer Research Center), Simeng Chen(Anhui University), Xi Xu(Brigham and Women's Hospital)
Cited by 0
Related Papers
Elevated frequencies of CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>lo</sup> regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia
|International Journal of Cancer|2010|202
Intravenous infusion of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia
|Stem Cell Research & Therapy|2020|182
The associations between endocrine disrupting chemicals and markers of inflammation and immune responses: A systematic review and meta-analysis
|Ecotoxicology and Environmental Safety|2022|127
Comprehensive human proteome profiles across a 50-year lifespan reveal aging trajectories and signatures
|Cell|2025|126
Hepatocyte Encapsulation for Enhanced Cellular Functions
|Tissue Engineering|2000|116